EDAP TMS, the world leader in therapeutic ultrasound
Global leader in therapeutic ultrasound and present in the market for more than 35 years, EDAP TMS (NASDAQ: EDAP) develops, manufactures, promotes and distributes minimally-invasive medical devices for urology using ultrasound technology. EDAP TMS is actively operating worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. By constantly investing in Research & Development, partnering with INSERM French public laboratory and internationally renowned medical research institutions, EDAP TMS has developed a strong valuable patent portfolio based on its innovative technologies.
HIFU (High Intensity Focused Ultrasound)
With its complete range of Robotic HIFU devices, Ablatherm® and Focal One®, EDAP TMS is the most innovative company in non-invasive treatment for Prostate Cancer. By combining the latest technologies in imaging and treatment modalities, EDAP TMS recently introduced the Focal One® device as the answer to current requirements for ideal focal therapy of prostate cancer and as a complement to the existing Ablatherm® HIFU.
ESWL (Extracorporeal ShockWave Lithotripsy)
As a pioneer and key player in the field of Extracorporeal ShockWave Lithotripsy, EDAP TMS introduced the first modular lithotripter. The latest generation of shockwave source (Electroconductive Technology) and stone localization (Visio-Track) are utilized exclusively by EDAP TMS in its Sonolith® range of ESWL systems (Sonolith® i-sys and Sonolith® i-move).
Stone Laser
To offer a complete range of minimally invasive solutions covering the full scope of urinary tract stone indications, EDAP TMS has integrated in its portfolio an user-friendly 30W Holmium:YAG Surgical Laser the Laserlith® i-dust.
